CVS vs LH
CVS Health (CVS) and Labcorp (LH) compared side by side. CVS Health (CVS) is larger, with a market cap of $119.5B versus $26.7B for Labcorp, about 4.5 times the size. On trailing earnings, CVS is cheaper at 24.6x versus 27.2x for LH.
Head to head
| Metric | CVS | LH |
|---|---|---|
| Market cap | $119.5B | $26.7B |
| P/E (TTM) | 24.6x | 27.2x |
| Forward P/E | 11.0x | 16.6x |
| Revenue (TTM) | $412.6B | $14.3B |
| Revenue growth | 7.1% | 5.8% |
| Gross margin | 13.6% | 28.9% |
| Operating margin | 3.9% | 12.2% |
| Free cash flow | $11.8B | $1.2B |
| Dividend yield | 2.85% | 0.88% |
| 1-year return | +18.8% | +17.0% |
| 5-year return (annual) | +4.8% | +7.4% |
| Max drawdown | -83% | -96% |
| FI Handbook grade | C- | C+ |
Highlighted: the stronger figure on metrics where higher or lower is clearly better.
Growth of $10,000 (5 years, price only)
CVS vs LH FAQ
Which is bigger, CVS or LH?
CVS Health (CVS) is larger, with a market cap of $119.5B versus $26.7B for Labcorp, about 4.5 times the size.
Is CVS or LH cheaper?
On trailing earnings, CVS is cheaper at 24.6x versus 27.2x for LH. A lower P/E can reflect slower expected growth, so compare growth and margins too.
Which stock performed better over the past year, CVS or LH?
CVS returned +18.8% over the past year including dividends, versus +17.0% for LH, through October 23, 2026.
Which pays a higher dividend, CVS or LH?
CVS yields 2.85% versus 0.88% for LH.
Full pages: CVS Health · Labcorp